Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1990
12/13/1990CA2033086A1 Chelating agents for attaching metal ions to proteins
12/13/1990CA2018959A1 Tetrahydro-5,6,7,8 naphtalenol-1 derivatives, process for their preparation and use as antioxidant in cosmetic compositions and pharmaceutical products containing same
12/12/1990EP0402300A2 Production of bacteria and yeast of hemoglobin and analogues thereof
12/12/1990EP0402275A1 Composition comprising thermoplastic silicone polymer and iodine compound and its use for the treatment of water after shaping process
12/12/1990EP0402266A2 N-substituted lauramides, their preparation and compositions containing them
12/12/1990EP0401896A1 Carboplatin composition
12/12/1990EP0401895A1 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
12/12/1990EP0401695A1 Etoposide preparation
12/12/1990EP0401625A2 Alternating copolymers, process for their preparation and their use
12/12/1990EP0401394A1 Stable aqueous cisplatin solutions
12/12/1990EP0401384A1 Chemically modified granulocyte colony stimulating factor
12/12/1990EP0401379A1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b)
12/12/1990EP0401247A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells
12/12/1990EP0401215A1 Hydrophilic carboxy polyurethanes
12/11/1990US4977280 Anticarcinogenic agents
12/11/1990US4977157 Aqueous preparation of 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a])pyrimidin-4-one potassium salt
12/11/1990US4977140 Injectable sustained release formulation
12/11/1990US4977139 Osteoporosis, Paget's disease
12/11/1990US4976969 Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
12/11/1990US4976965 Coronary affecting medicinal composition
12/11/1990US4976962 Biodegradable polypeptide and the use thereof for the gradual release of drugs
12/11/1990CA1277672C Process for preparing highly pure cyclic esters
12/11/1990CA1277613C Monoclonal antibodies, a process for their preparation and their use
12/11/1990CA1277612C Monoclonal antibodies with specificity for membrane- associated antigens
12/11/1990CA1277596C Continuous release peptide compositions
12/09/1990CA2017986A1 Alternating copolymers, a process for their preparation, and a method of use thereof
12/09/1990CA2013017A1 Aqueous preparation of pyrido¬1,2-a|pyrimidine compound
12/08/1990WO1990015059A1 Photosensitizing diels-alder porphyrin derivatives
12/08/1990WO1990014833A1 Slow release vehicles for minimizing skin irritancy of topical compositions
12/08/1990WO1990014821A1 A fructose-based granulated product and a process for the production thereof
12/08/1990CA2056431A1 Photosensitizing diels-alder porphyrin derivatives
12/08/1990CA2018641A1 N-substituted lauramides, their preparation and compositions in which they are present
12/08/1990CA2018408A1 Composition including a thermoplastic silicone copolymer and an iodine compound used, once formed, in water treatment
12/07/1990CA2018248A1 Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
12/06/1990WO1990015586A2 Bioerodible polymers for drug delivery in bone
12/05/1990EP0400910A2 Shaped articles containing liquefiable powders for delivery of cosmetic and other personal care agents
12/05/1990EP0400637A2 Preparation of FR115224 substance for parenteral administration
12/05/1990EP0400609A1 Intravenous solutions with quick action onset
12/05/1990EP0400546A1 Stable anhydrous compositions for topical delivery of active materials
12/05/1990EP0400522A2 Process for the preparation of micronised biodegradable particles
12/05/1990EP0400486A2 Polyethylene glycol derivatives, modified peptides and production thereof
12/05/1990EP0400472A2 Process for preparing polyethylene glycol derivatives and modified protein.
12/05/1990EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
12/05/1990EP0400015A1 Hydrophilic polyurethanes of improved strength
12/05/1990EP0375773A4 Topical hematoporphyrin
12/05/1990EP0105924B1 Dry powder formulations having improved flow and compressibility characteristics, and method for the preparation thereof
12/05/1990CN1047501A Process for preparing aromatic ether
12/05/1990CA2016244A1 Pvp-hi-i complexes having a partition coefficient above 300, and process for making same
12/04/1990US4975465 Orally administrable ibuprofen compositions
12/04/1990US4975420 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
12/04/1990US4975371 High viscous substance BS-1 and process for producing the same
12/04/1990US4975283 Mixing with glutamic acid hydrochloride
12/04/1990US4975282 Multilamellar liposomes having improved trapping efficiencies
12/04/1990US4975281 Agent forming protective complex in acid environment and alkaline material; preventing formation in and adherence to mouth
12/04/1990US4975278 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
12/04/1990US4975271 Muscosal delivery systems for treatment of periodontal disease
12/04/1990US4975269 Shelf stable aspirin solutions
12/04/1990CA1277238C Solid, stable dosage forms with an elastic film coating
12/04/1990CA1277236C Sustained-release formulation containing an amino acid polymer
12/04/1990CA1277235C Sustained-release formulation containing an amino acid polymer with alower alkyl (c -c ), polar solvent
12/02/1990CA2017959A1 Intravenous solutions with a rapid onset of action
12/02/1990CA2017156A1 Preparation of fr115224 substance for parenteral administration
12/01/1990CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
11/1990
11/30/1990CA2015075A1 Shaped articles containing liquefiable powders for delivery of cosmetic and other personal care agents
11/29/1990WO1990014435A1 Methods, reagents and test kits for determination of subpopulations of biological entities
11/29/1990WO1990014110A1 Improvements in or relating to pharmaceutical preparations
11/29/1990WO1990014104A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
11/29/1990WO1990014103A1 Polypeptide-antibody conjugate for inhibiting cell adhesion
11/29/1990WO1990014089A1 New imipramine-based compositions
11/29/1990WO1990014082A1 Retinoic acid-based aqueous gel
11/29/1990WO1990014077A1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS
11/29/1990WO1990014073A1 Pharmaceutical preparation
11/29/1990WO1990010448A3 Covalent conjugates of lipid and oligonucleotide
11/29/1990CA2051373A1 Methods, reagents and test kits for determination of subpopulations of biological entities
11/28/1990EP0399903A1 Pharmaceutical compositions containing imipramine
11/28/1990EP0399902A1 Porous pharmaceutical form and process to prepare it
11/28/1990EP0399899A1 Process for the preparation of aromatic ethers
11/28/1990EP0399858A1 Cleansing composition containing in particular naftifine and/or terbinafine
11/28/1990EP0399843A2 Adjuvant formulation comprising a submicron oil droplet emulsion
11/28/1990EP0399827A2 Modified polyester composition and preparation process and use thereof
11/28/1990EP0399781A1 Stabilized calcitonin pharmaceutical composition
11/28/1990EP0399716A1 Hypoallergenic steroidal anesthetic/hypnotic compositions
11/28/1990EP0399435A2 Crosslinked carboxymethylguar tablet disintegrant
11/28/1990EP0399432A2 Transdermal therapeutic composition
11/28/1990EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY
11/28/1990EP0398925A1 Growth inhibiting agent and the use thereof.
11/28/1990CN1047204A Stable solution of rebeccamycin analog and preparation thereof
11/28/1990CN1010551B Process for preparation of injection composition comprising antibacterial aminoglycoside
11/28/1990CN1010549B Conveying system for sweets base substances or active medium
11/27/1990WO1990014094A1 Injectable clarithromycin composition
11/27/1990US4973708 Transdermal enhancer for penetration of drugs through the skin
11/27/1990US4973680 Organosiloxane-containing polysaccharides
11/27/1990US4973638 Polyamide resin and method for preparation of reagents for immunodiagnostic use
11/27/1990US4973591 Salt formation in situ, treatment of strokes
11/27/1990US4973579 Viricides
11/27/1990US4973493 Method of improving the biocompatibility of solid surfaces
11/27/1990US4973469 Active material adsorbed on crosslinked polymer, inactive material controls solubility
11/27/1990US4973468 Skin permeation enhancer compositions
11/27/1990US4973465 Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
11/27/1990US4972848 Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
1 ... 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 ... 1712